CHX15 Antibody

Shipped with Ice Packs
In Stock

Description

Potential Confusion with "VX15" Antibody

The search results reference VX15, a monoclonal antibody under investigation for Huntington’s disease (HD) in the SIGNAL trial (NCT04558982) . Key details:

ParameterDescription
TargetSemaphorin 4D (SEMA4D)
MechanismBlocks SEMA4D-mediated inflammation in HD brains
Trial PhasePhase II (Cohort B ongoing)
Primary OutcomeSafety, tolerability, and cognitive/motor function changes
Secondary OutcomesBiomarkers of neuroinflammation and neuronal health

Note: "VX15" is distinct from "CHX15," but its clinical context aligns with potential therapeutic antibody research.

CBX1 Antibody

CBX1 (Chromobox Protein Homolog 1) is a histone H3K9 methyl-binding protein critical for heterochromatin formation. Antibodies targeting CBX1 are widely used in epigenetics research:

AntibodySourceApplicationsKey FindingsReferences
ab10811 (Rat monoclonal)Abcam IP, ChIP, ELISA, WB, IFDetects CBX1 in nuclear heterochromatin; validated using KO cell lines
11733-1-AP (Rabbit polyclonal)Proteintech WB, IHC, IF, IPReacts with human/mouse/rat CBX1; used in Parkinson’s disease models

Clinical Relevance: Elevated CBX1 antibodies (e.g., CBX1-Abs) correlate with cerebrovascular incidents (e.g., transient ischemic attack, acute cerebral infarction) .

CHD1 Antibody

CHD1 (Chromodomain Helicase DNA Binding Protein 1) regulates chromatin remodeling. Antibodies targeting CHD1 are used in cancer and neurodegenerative studies:

AntibodySourceApplicationsKey FindingsReferences
A01175-1 (Rabbit Picoband®)Boster Bio WB, IHC, ELISA, Flow CytometryDetects CHD1 in brain tissue; validated in paraffin-embedded sections

Antibody Validation Challenges

  • Specificity Issues: ~50% of commercial antibodies fail in one or more applications (e.g., Western blot, immunofluorescence) .

  • Recombinant vs. Conventional Antibodies: Recombinant antibodies outperform monoclonal/polyclonal ones in cross-application performance .

  • KO Cell Line Validation: Knockout (KO) cell lines are superior controls for antibody specificity, reducing false positives in assays .

Therapeutic Antibodies in Neurodegeneration

  • VX15: Targets SEMA4D to mitigate neuroinflammation in HD .

  • CUX1 Antibodies: Used in Parkinson’s disease models to study cortical neuron development .

Recommendations for Future Research

  1. Nomenclature Standardization: Confirm the correct target (e.g., SEMA4D, CBX1, CHD1) to align with established literature.

  2. Collaborative Validation: Leverage initiatives like YCharOS to test antibody performance across applications .

  3. Clinical Translation: For HD, prioritize antibodies targeting neuroinflammatory pathways (e.g., SEMA4D, IL-6) .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
CHX15 antibody; At2g13620 antibody; T10F5.16Cation/H(+) antiporter 15 antibody; Protein CATION/H+ EXCHANGER 15 antibody; AtCHX15 antibody
Target Names
CHX15
Uniprot No.

Target Background

Function
CHX15 Antibody may function as a cation/H(+) antiporter.
Database Links

KEGG: ath:AT2G13620

STRING: 3702.AT2G13620.1

UniGene: At.52727

Protein Families
Monovalent cation:proton antiporter 2 (CPA2) transporter (TC 2.A.37) family, CHX (TC 2.A.37.4) subfamily
Subcellular Location
Membrane; Multi-pass membrane protein.
Tissue Specificity
Specifically expressed in pollen.

Q&A

What is CHX15 Antibody and what is its target specificity?

CHX15 Antibody is a Rabbit Polyclonal antibody that specifically recognizes antigens from Arabidopsis thaliana, particularly those associated with the CATION/H+ EXCHANGER 15 gene (ATCHX15). As a polyclonal antibody, it contains a heterogeneous mixture of antibodies that recognize multiple epitopes on the target antigen, providing robust detection capabilities across different experimental conditions. The antibody targets proteins involved in cation/H+ exchange mechanisms in plant cells, which play crucial roles in cellular pH regulation and ion homeostasis .

What are the validated applications for CHX15 Antibody?

CHX15 Antibody has been validated for several key molecular biology applications. These include Enzyme Immunoassay (EIA), general immunoassay protocols, Enzyme-Linked Immunosorbent Assay (ELISA), and Western Blot techniques. The antibody has shown particular effectiveness in detecting recombinant immunogen proteins and peptides in Western Blot applications, making it a versatile tool for diverse experimental approaches in plant molecular biology research .

How does sample preparation affect CHX15 Antibody performance?

Proper sample preparation is critical for optimal CHX15 Antibody performance. For plant tissue samples, researchers should consider:

  • Fresh tissue extraction using appropriate buffer systems that maintain protein integrity while minimizing proteolytic degradation

  • Inclusion of protease inhibitors and reducing agents in extraction buffers

  • Careful temperature control during extraction (typically 4°C)

  • Centrifugation parameters that separate cellular debris while retaining target proteins

  • Protein quantification prior to antibody application to ensure consistent loading

The performance of the antibody may vary depending on whether samples are native, denatured, or fixed, with Western Blot applications typically requiring denatured proteins while some immunoassays may perform better with native conformations.

What controls should be included when working with CHX15 Antibody?

Rigorous experimental design with CHX15 Antibody requires multiple controls:

  • Positive control: Use of known CHX15-expressing Arabidopsis thaliana samples or recombinant CHX15 protein

  • Negative control: Samples from CHX15 knockout plants or tissues known not to express CHX15

  • Antibody controls: Secondary antibody-only controls to assess non-specific binding

  • Loading controls: Housekeeping proteins (e.g., actin, tubulin) for Western Blot normalization

  • Blocking peptide control: Pre-incubation of antibody with synthetic CHX15 peptide to confirm specificity

These controls help distinguish specific signals from background and validate experimental findings, particularly important given the polyclonal nature of this antibody.

How can researchers optimize Western Blot protocols for CHX15 detection?

For optimal Western Blot detection of CHX15 in plant samples, researchers should consider:

  • Sample preparation: Use SDS-based lysis buffers containing DTT or β-mercaptoethanol as reducing agents

  • Gel percentage: 10-12% polyacrylamide gels typically provide good resolution for CHX15 detection

  • Transfer conditions: Semi-dry transfer (15-20V for 30-45 minutes) or wet transfer (30V overnight at 4°C)

  • Blocking: 5% non-fat dry milk or BSA in TBST for 1-2 hours at room temperature

  • Primary antibody: Dilute CHX15 Antibody 1:1000 to 1:2000 in blocking solution; incubate overnight at 4°C

  • Washing: 3-5 washes with TBST, 5-10 minutes each

  • Secondary antibody: Anti-rabbit HRP-conjugated secondary antibody at 1:5000 to 1:10000 dilution

  • Detection: Use enhanced chemiluminescence (ECL) substrate with exposure times optimized for signal intensity

Optimization may be required for specific research questions, including adjusting antibody concentrations and incubation times based on signal strength and background levels.

How can CHX15 Antibody be utilized to study cation/H+ exchange mechanisms in plants?

CHX15 Antibody enables sophisticated studies of cation/H+ exchange mechanisms through:

  • Immunolocalization studies to determine subcellular localization of CHX15 exchangers

  • Co-immunoprecipitation experiments to identify protein interaction partners

  • Comparative expression analysis across different plant tissues and developmental stages

  • Investigation of CHX15 expression changes under ionic stress conditions

  • Combined approaches with electrophysiological measurements to correlate protein presence with functional activity

These applications provide insights into how plants regulate cellular pH and ion homeostasis, which are essential for understanding plant responses to environmental stresses such as salinity and drought.

What methodologies can resolve contradictory results when using CHX15 Antibody?

When faced with contradictory results using CHX15 Antibody, researchers should implement a systematic troubleshooting approach:

  • Antibody validation: Verify antibody specificity using Western Blot against recombinant CHX15 protein

  • Multiple detection methods: Compare results across different techniques (ELISA, Western Blot, immunofluorescence)

  • Technical replication: Perform experiments with consistent protocols across multiple independent samples

  • Biological validation: Correlate antibody-based detection with gene expression analysis (RT-qPCR)

  • Alternative antibody sources: Compare results with independently produced CHX15 antibodies if available

  • Epitope mapping: Determine which regions of CHX15 are recognized by the polyclonal antibody

  • Literature comparison: Contextualize findings within published research on CHX15 and related cation/H+ exchangers

This methodical approach helps distinguish between technical artifacts and genuine biological variability.

How can CHX15 Antibody be incorporated into plant stress response studies?

CHX15 Antibody provides valuable tools for investigating plant stress responses:

  • Time-course experiments examining CHX15 protein expression during exposure to salt, drought, or pH stress

  • Comparative protein abundance measurement across wild-type and stress-tolerant plant varieties

  • Correlation of CHX15 protein levels with physiological parameters of stress tolerance

  • Investigation of post-translational modifications of CHX15 under different stress conditions

  • Integration with transcriptomic data to understand regulatory mechanisms controlling CHX15 expression

These approaches help elucidate the role of cation/H+ exchangers in plant adaptation to environmental challenges, potentially informing strategies for developing stress-resistant crops.

How should researchers address non-specific binding when using CHX15 Antibody?

Non-specific binding can complicate CHX15 Antibody experiments. Researchers can mitigate this through:

  • Optimization of blocking conditions: Test different blocking agents (milk, BSA, casein) and concentrations

  • Increasing wash stringency: Use higher detergent concentrations or longer wash steps

  • Antibody dilution optimization: Titrate primary antibody to find optimal signal-to-noise ratio

  • Pre-adsorption: Incubate antibody with proteins from non-target tissues to remove cross-reactive antibodies

  • Reducing primary antibody incubation time or temperature

  • Using more specific detection systems with lower background

If persistent non-specific binding occurs, researchers should consider using monoclonal antibodies or affinity-purified antibody preparations if available.

What methods can verify the specificity of CHX15 Antibody?

Verifying CHX15 Antibody specificity requires multiple approaches:

  • Western Blot analysis showing bands of expected molecular weight

  • Comparison of signals between wild-type and CHX15 knockout or knockdown plants

  • Peptide competition assays demonstrating signal reduction with specific blocking peptides

  • Mass spectrometry identification of immunoprecipitated proteins

  • Correlation between protein detection and known gene expression patterns

  • Signal absence in tissues that naturally lack CHX15 expression

  • Consistent results across different sample preparation methods

These verification steps are essential before embarking on extensive research projects using the CHX15 Antibody.

How can CHX15 Antibody be used in studying plant membrane trafficking?

CHX15 Antibody offers opportunities to investigate membrane trafficking processes:

  • Immunofluorescence microscopy to track CHX15 localization during vesicle trafficking

  • Subcellular fractionation followed by immunoblotting to identify membrane compartments containing CHX15

  • Co-localization studies with known membrane markers to define CHX15 trafficking pathways

  • Live-cell imaging using CHX15 Antibody-derived Fab fragments

  • Combination with inhibitors of membrane trafficking to assess impact on CHX15 distribution

These approaches help understand how plant cells regulate the distribution of ion transporters in response to developmental cues and environmental stimuli.

What considerations apply to using CHX15 Antibody in multiplex immunoassays?

When incorporating CHX15 Antibody into multiplex assays, researchers should consider:

  • Antibody cross-reactivity: Test for potential interactions with other primary antibodies in the multiplex panel

  • Secondary antibody compatibility: Ensure secondary antibodies with minimal cross-species reactivity

  • Signal intensity balancing: Adjust concentrations of each primary antibody to achieve comparable signal strength

  • Spectral overlap: Choose fluorophores with minimal spectral overlap for immunofluorescence applications

  • Sequential detection protocols: Consider sequential rather than simultaneous antibody incubations if cross-reactivity occurs

  • Control samples: Include single-antibody controls alongside multiplex experiments

These considerations help generate reliable data from complex experimental setups investigating multiple proteins simultaneously.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.